Edward Faber
Hematology & Oncology · Cincinnati, OHNPI 1326163981
Payments from drug & device makers
Across 579 payments — averaging $3908.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1.1M
- Genentech, Inc.$279K
- Janssen Research & Development, LLC$251K
- AbbVie$224K
- Incyte Corporation$163K
- Sanofi$51K
- plus $151K from 23 others
Across 1 payment — averaging $4000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Scientific Affairs, LLC$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 26 | $1,144,894 |
| Genentech, Inc. | 25 | $279,094 |
| Janssen Research & Development, LLC | 212 | $250,709 |
| AbbVie | 21 | $224,085 |
| Incyte Corporation | 194 | $162,533 |
| Sanofi | 3 | $50,937 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $44,168 |
| GSK | 8 | $41,469 |
| E.r. Squibb & Sons, L.L.C. | 15 | $21,406 |
| Bristol Myers Squibb | 13 | $9,434 |
| Johnson & Johnson(2 entities) | 15 | $8,135 |
| AstraZeneca | 2 | $5,951 |
| Gilead | 5 | $4,694 |
| Karyopharm Therapeutics Inc. | 3 | $3,023 |
| Adaptive Biotechnologies Corporation | 3 | $2,700 |
| Janssen Scientific Affairs, LLC | 6 | $2,338 |
| Blueprint Medicines Corporation | 1 | $1,980 |
| CTI Biopharma Corp. | 1 | $1,725 |
| Janssen Global Services, LLC | 2 | $1,635 |
| Epizyme, Inc. | 2 | $1,262 |
| Aurobindo Pharma USA, Inc. | 3 | $287 |
| Legend Biotech USA Inc. | 2 | $143 |
| Lilly USA, LLC | 1 | $100 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $31 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Bayer | 1 | $13 |
How this compares
$2,262,832 in reported general payments places this provider in the 90th percentile of 450 hematology & oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Cincinnati
- Trisha Wise-DraperCincinnati$9.8M
- Davendra SohalCincinnati$8.6M
- David WaterhouseCincinnati$5.7M
- Patrick WardCincinnati$3.8M
- James EssellCincinnati$3.7M
- Omar AlkharabshehCincinnati$1.2M
- Alexander StarodubCincinnati$1.1M
- Mark JohnsCincinnati$999K
- Jason JonesCincinnati$948K
- Shuchi GulatiCincinnati$792K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.